Exact Mass: 277.110273
Exact Mass Matches: 277.110273
Found 500 metabolites which its exact mass value is equals to given mass value 277.110273
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
METAZACHLOR
C14H16ClN3O (277.09818359999997)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 269 CONFIDENCE standard compound; INTERNAL_ID 3539 CONFIDENCE standard compound; INTERNAL_ID 8416 CONFIDENCE standard compound; INTERNAL_ID 4036 CONFIDENCE standard compound; INTERNAL_ID 31
Queuine
Queuine is a highly modified derivative of guanine found in the first position of the anticodon of the transfer RNAs for asp, asn, his and tyr. The original transcripts of these tRNAs contain guanine in this position. All organisms with the exception of yeast and mycoplasma contain queuine. Bacteria synthesize queuine but it cannot be synthesized by higher mammals. Significant amounts of free queuine are present in common plant and animal food products. (PMID 9016755) [HMDB] Queuine is a highly modified derivative of guanine found in the first position of the anticodon of the transfer RNAs for asp, asn, his and tyr. The original transcripts of these tRNAs contain guanine in this position. All organisms with the exception of yeast and mycoplasma contain queuine. Bacteria synthesize queuine but it cannot be synthesized by higher mammals. Significant amounts of free queuine are present in common plant and animal food products. (PMID 9016755).
S-(2-Methylpropionyl)-dihydrolipoamide-E
S-(2-Methylpropionyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15977). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 2-methyl-1-hydroxypropyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to isobutyryl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168]. [HMDB] S-(2-Methylpropionyl)-dihydrolipoamide-E is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15977). It is the second to last step in the synthesis of branched chain fatty acid and is converted from 2-methyl-1-hydroxypropyl-ThPP via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to isobutyryl-CoA via the enzyme dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168].
trans-2-((Dimethylamino)methylimino)-5-(2-(5-nitro-2-furyl)vinyl)-1,3,4-oxadiazole
JNJ-7777120
C14H16ClN3O (277.09818359999997)
JNJ-7777120 is a potent and selective histamine H4 receptor antagonist (Ki=4.5 nM). JNJ-7777120 effectively blocks histamine-induced migration of mouse tracheal mast cells from connective tissue to epithelial cells. JNJ-7777120 also significantly blocks neutrophil infiltration in a mouse Zymosan-induced peritonitis model. JNJ-7777120 has a good potential to study antipruritic and anti-inflammatory[1][2].
Dehydroaporheine
Dehydroaporheine is found in coffee and coffee products. Dehydroaporheine is an alkaloid from Nelumbo nucifera (East India lotus) and Papaver rhoeas (corn poppy). Alkaloid from Nelumbo nucifera (East India lotus) and Papaver rhoeas (corn poppy). Dehydroaporheine is found in coffee and coffee products and root vegetables.
Murrayacine
Murrayacine is found in herbs and spices. Murrayacine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Murrayacine is found in herbs and spices.
Lysylmethionine
Lysylmethionine is a dipeptide composed of lysine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Methionyl-Lysine
Methionyl-Lysine is a dipeptide composed of methionine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Methionyl-Glutamine
Methionyl-Glutamine is a dipeptide composed of methionine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Entecavir
Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS). Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
Arginylcysteine
Arginylcysteine is a dipeptide composed of arginine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Cysteinyl-Arginine
Cysteinyl-Arginine is a dipeptide composed of cysteine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Glutaminylmethionine
Glutaminylmethionine is a dipeptide composed of glutamine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Methionyl-Gamma-glutamate
Methionyl-Gamma-glutamate is a dipeptide composed of methionine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
N-(1-Deoxy-1-fructosyl)proline
Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)proline is classified as a Natural Food Constituent (code WA) in the DFC.
3'-Deaminofusarochromanone
3-Deaminofusarochromanone is produced by Fusarium equiseti. Production by Fusarium equiseti
2-Naphthalenecarboxamide, 3-hydroxy-N-(2-methylphenyl)-
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
1H-Indole-4,6-dicarboximidamide, 2-phenyl-
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
7-Hydroxyflumequine
carboxy-ptio
3-[(2Z,3E)-3-(Hydroxyimino)-2,3-dihydro-1H-indol-2-ylidene]-2,3-dihydro-1H-indol-2-one
Indirubin-3'-monoxime
Indirubin-3'-monoxime is a potent GSK-3β inhibitor, and weakly inhibits 5-Lipoxygenase, with IC50s of 22 nM and 7.8-10 μM, respectively; Indirubin-3'-monoxime also shows inhibitory activities against CDK5/p25 and CDK1/cyclin B, with IC50s of 100 and 180 nM.
1-[(5-Chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine
C14H16ClN3O (277.09818359999997)
JNJ-7777120 is a potent and selective histamine H4 receptor antagonist (Ki=4.5 nM). JNJ-7777120 effectively blocks histamine-induced migration of mouse tracheal mast cells from connective tissue to epithelial cells. JNJ-7777120 also significantly blocks neutrophil infiltration in a mouse Zymosan-induced peritonitis model. JNJ-7777120 has a good potential to study antipruritic and anti-inflammatory[1][2].
Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid
2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
(2R,3S,5R)-5-(4,5-Dihydroimidazo[2,1-f]purin-3-yl)-2-(hydroxymethyl)oxolan-3-ol
3-Nitro-3,3a-dihydrobenzo[b]phenalen-7-one
C17H11NO3 (277.07388960000003)
Arginyl-Cysteine
3alpha-Phenylacetoxy-6beta,7beta-dihydroxynortropane
N-(4-Cyano-3-methylpyrido[1,2-a]benzimidazol-1-yl)-N,N-dimethyliminoformamide
N2-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine
MEX_278.1387_17.3
CONFIDENCE Identification confirmed with Reference Standard synthesized at Eawag (Level 1); INTERNAL_ID 908 INTERNAL_ID 908; CONFIDENCE Identification confirmed with Reference Standard synthesized at Eawag (Level 1)
(2E,4E)-N-phenethylundeca-2,4-dien-8,10-diynamide|2-Phenylethylamide-(2E,4E)-2,4-Undecadiene-8,10-diynoic acid
2-methoxy-4,5-methylenedioxy-trans-cinnamoylisobutylamide
N-[6-(Acetoxymethyl)-3,4-dihydro-4-oxopteridine-2-yl]acetamide
5-acetamido-2,7-anhydro-3,5-dideoxy-alpha-D-glycero-D-galacto-nonulopyranose
desulfo-but-3-enyl GL|desulfogluconapin|DS-GNA
C11H19NO5S (277.09838840000003)
6beta-benzoyloxytropan-3alpha,7beta-diol|6beta-Benzoyloxytropane-3alpha,7beta-diol
4-(5-amino-6-benzylpyrazin-2-yl)phenol
(+/-)-4-(2,3-Dihydroxy-3-methylbutoxy)-1-methyl-1H-quinolin-2-one|4-(2,3-Dihydroxy-3-methylbutoxy)-1-methyl-2(1H)-quinolinone|4-(2,3-dihydroxy-3-methylbutoxy)-1-methylquinolin-2(1H)-one
p-Toluolsulfonsaeure-(4-methylamino-phenyl)-ester|toluene-4-sulfonic acid-(4-methylamino-phenyl ester)|Toluol-4-sulfonsaeure-(4-methylamino-phenylester)
N-(2-Phenylethyl)-3,5-undecadiene-8,10-diynamide|undeca-3E,5E-dien-8,10-diynoic acid 2-phenylethylamide
1-(1,1-Dimethyl-2,3-dihydroxypropyl)-1H-indole-3-carboxylic acid methyl ester
3-hydroxyheteroendrin|Nitrile,2-O-beta-D-glucopyranoside-(R)-2,3-Dihydroxy-3-methylbutanoic acid
INDIRUBIN-3-MONOXIME
A member of the class of biindoles that is indirubin in which the keto group at position 3 has undergone condensation with hydroxylamine to form the corresponding oxime. Indirubin-3'-monoxime is a potent GSK-3β inhibitor, and weakly inhibits 5-Lipoxygenase, with IC50s of 22 nM and 7.8-10 μM, respectively; Indirubin-3'-monoxime also shows inhibitory activities against CDK5/p25 and CDK1/cyclin B, with IC50s of 100 and 180 nM.
C15H19NO4_2-Pentenamide, 2-methyl-5-[(1R,3S,6R,9S)-6-methyl-8-oxo-7-oxatricyclo[4.3.0.0~3,9~]non-9-yl]-4-oxo-, (2E)
Methyltriphenylphosphonium
CONFIDENCE standard compound; INTERNAL_ID 2495
(5S,1R)-8-azabicyclo(3.2.1)oct-3-yl 4-hydroxy-3-methoxybenzoate
Origin: Plant; Formula(Parent): C15H19NO4; Bottle Name:Convolidine; PRIME Parent Name:Convolidine; PRIME in-house No.:V0341; SubCategory_DNP: Alkaloids derived from ornithine, Tropane alkaloids
Etocrilene
C1892 - Chemopreventive Agent > C851 - Sunscreen CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9264; ORIGINAL_PRECURSOR_SCAN_NO 9261 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9311; ORIGINAL_PRECURSOR_SCAN_NO 9309 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9325; ORIGINAL_PRECURSOR_SCAN_NO 9323 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9368; ORIGINAL_PRECURSOR_SCAN_NO 9366 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9368; ORIGINAL_PRECURSOR_SCAN_NO 9367 CONFIDENCE standard compound; INTERNAL_ID 732; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9377; ORIGINAL_PRECURSOR_SCAN_NO 9375
S-(2-Methylpropionyl)-dihydrolipoamide-E
Entecavir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
Lys-met
A dipeptide formed from L-lysine and L-methionine residues.
Met-GLN
A dipeptide formed from L-methionine and L-glutamine residues.
Met-lys
A dipeptide formed from L-methionine and L-lysine residues.
Dehydroremerine
3'-Deaminofusarochromanone
tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
C14H20BNO4 (277.14853100000005)
N-[3-[2-cyanoethyl(2-hydroxyethyl)amino]-4-methoxyphenyl]acetamide
2-CBZ-AMINO-4-METHYLPENT-2-ENOIC ACID METHYL ESTER
ethyl 3-amino-5-(4-methoxyphenyl)thiophene-2-carboxylate
4-[[(2,5-dimethylfuran-3-carbonyl)amino]methyl]-5-methylfuran-2-carboxylic acid
4-Quinolinecarboxylicacid, 3-methyl-2-phenyl-, methyl ester
5-propan-2-yl-7-(trifluoromethyl)-1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid
(7-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)b oronic acid
(6-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)b oronic acid
(5-Hydroxy-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-1H-indol-2-yl)b oronic acid
methyl 5,5,5-trifluoro-4-(4-fluorophenyl)iminopentanoate
Methyl 5,5,5-trifluoro-4-(4-fluorophenylamino)pent-3-enoate
Guanidine,N-(4-chlorophenyl)-N-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-
Methyl (1S,2R,3S,4R)-3-[(4-fluorobenzyl)amino]bicyclo[2.2.1]hepta ne-2-carboxylate
6-METHYL-2-(2-METHYLPHENYL)QUINOLINE-4-CARBOXYLICACID
6-Methyl-2-(3-methylphenyl)quinoline-4-carboxylic acid
8-METHYL-2-(2-METHYLPHENYL)QUINOLINE-4-CARBOXYLICACID
8-Methyl-2-(3-methylphenyl)quinoline-4-carboxylic acid
8-METHYL-2-(4-METHYLPHENYL)QUINOLINE-4-CARBOXYLICACID
(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl 2,2-dimethylpropanoate
(R)-3,4-DIHYDRO-2H-QUINOLINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER
2,5-Cyclohexadien-1-one,4-[[4-hydroxy-2-methyl-5-(1-methylethyl)phenyl]imino]-, sodium salt (1:1)
C16H16NNaO2 (277.10786759999996)
11H-Benzo[a]carbazole-3-carboxylicacid, 2-hydroxy-
C17H11NO3 (277.07388960000003)
2-methyl-1-N-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,4-diamine
ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate
C14H20BNO4 (277.14853100000005)
methyl 2-{[(benzyloxy)carbonyl]amino}-2-(oxetan-3-ylidene)acetate
2-[(1R)-1-[[(1R)-1-phenylethyl]amino]ethyl]phenol,hydrochloride
Pentanoic acid, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-4-methyl-, (2S)-
N-(2-methyl-5-phenylpyrrol-1-yl)pyridine-4-carboxamide
CIS-DIMETHYL 1-BENZYLPYRROLIDINE-3,4-DICARBOXYLATE
BENZYL-[1-(4-METHOXYPHENYL)ETHYL]AMINEHYDROCHLORIDE
(3R,4S)-4-Phenyl-3-[(Triethylsilyl)Oxy]-2-Azetidinone
N-BOC-1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBOXYLIC ACID
methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
C14H20BNO4 (277.14853100000005)
4-OXO-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-BENZYL ESTER
ETHYL 2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISONICOTINATE
C14H20BNO4 (277.14853100000005)
(5S)-N-(tert-Butoxycarbonyl)-3,4,5,6-tetrahydro-5-phenyl-4(h)-1,4-oxazin-2-one
trans-4-(carbobenzoxyamino)cyclohexanecarboxylic acid
2-AMINO-4-(4-ETHOXYPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID
5-[(3-Methoxyphenylamino)Methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
2-Boc-1,2,3,4-Tetrahydroisoquinoline-5-Carboxylic Acid
4-chloro-3-[[(4-methoxyphenyl)methylamino]methyl]pyridin-2-amine
C14H16ClN3O (277.09818359999997)
ETHYL 2-METHYL-2-((5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)OXY)PROPANOATE
(1R)-2-[(2-methylpropan-2-yl)oxycarbonyl]-3,4-dihydro-1H-isoquinoline-1-carboxylic acid
ethyl 5-amino-3-methylsulfanyl-1-phenylpyrazole-4-carboxylate
N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine
1-(2-chloro-1-adamantyl)-N-methylpropan-2-amine,hydrochloride
C14H25Cl2N (277.13639500000005)
3-BENZOYLQUINOLINE-4-CARBOXYLICACID
C17H11NO3 (277.07388960000003)
2,3-dihydro-1h-indole-3-carboxylic acid methyl ester
1-[(benzyloxy)carbonyl]-3-methylpiperidine-3-carboxylic acid
(1s,2r)-n-boc-1-amino-2-phenylcyclopropanecarboxylic acid
3-{[(Benzyloxy)carbonyl]amino}cyclohexanecarboxylic acid
(1R,3S)-3-(Carbobenzoxyamino)cyclohexanecarboxylic Acid
6,7-DIETHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
(1r,2r)-n-boc-1-amino-2-phenylcyclopropanecarboxylic acid
(4s)-4-[(1r)-2-azido-1-(benzyloxy)ethyl]-2,2-dimethyl-1,3-dioxolane
methyl 4-(tert-butylcarbonylamino)cubanecarboxylate
2-(o-tolylaminomethylene)malonic acid diethyl ester
2-METHYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER
2-AMINO-1-(3-(BENZYLOXY)PHENYL)ETHANONE HYDROCHLORIDE
C15H16ClNO2 (277.08695059999997)
2-Boc-1,2,3,4-Tetrahydroisoquinoline-8-Carboxylic Acid
Pentanoic acid, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]-4-methyl-,(2R)-
N-(4-HYDROXY-PHENYL)-4,N-DIMETHYL-BENZENESULFONAMIDE
4-(acetyloxy)-1-benzylpiperidine-4-carboxylic acid
1H-Benz[g]indole-3-carboxaldehyde,2-cyclohexyl-(9CI)
4-Fluoro-3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
3-(4-TERT-BUTOXYPHENYL)-2-ISOCYANATOPROPIONICACIDMETHYLESTER
1-(Piperidin-4-yl)piperazine trihydrochloride
C9H22Cl3N3 (277.08792220000004)
5-(3-Chlorobenzyl)-4-ethoxy-6-methyl-2-pyrimidinamine
C14H16ClN3O (277.09818359999997)
Ethyl 3-((dimethylamino)methyl)-5-methoxy-1H-pyrrolo[2,3-c]pyridine-2-carboxylate
(5r)-n-(tert-butoxycarbonyl)-3,4,5,6-tetrahydro-5-phenyl-4(h)-1,4-oxazin-2-one
2,2-[(4-Amino-3-nitrophenyl)imino]bisethanol hydrochloride
1H-Indene-1,3(2H)-dione,2-[[4-(dimethylamino)phenyl]methylene]-
3-cyclohexyl-4-oxo-10-oxa-3-azatricyclo[5.2.1.0~1,5~]dec-8-ene-6-carboxylic acid(SALTDATA: FREE)
1-Boc-1,2,3,4-tetrahydro-quinoline-2-carboxylic acid
1,2-Ethanedione, 1-(6-Methyl-2-pyridinyl)-2-(6-quinoxalinyl)-
4-(morpholin-4-yl)benzenediazonium tetrafluoroborate
ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate
C14H20BNO4 (277.14853100000005)
(S)-1-BOC-3,4-DIHYDRO-2H-QUINOLINE-2-CARBOXYLIC ACID
Sodium theophylline glycinate
C9H12N5NaO4 (277.07869519999997)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Ethyl 2-amino-4-(4-methoxyphenyl)-3-thiophenecarboxylate
(3R,4R)-N-CBZ-3,4-DIFLUOROPYRROLIDINEHYDROCHLORIDE
1,2(1H)-Isoquinolinedicarboxylicacid, 3,4-dihydro-, 2-(1,1-dimethylethyl) ester
2-[(7-hydroxy-4-methyl-2-oxo-chromen-6-yl)methyl-methyl-ammonio]acetate
(1S,2S)-1-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)-2-phenylcyc lopropanecarboxylic acid
2-(METHYLTHIO)-4-[(2-METHOXYPHENYL)AMINO]-5-PYRIMIDINEMETHANOL
5-(Ethoxycarbonyl)pyridine-3-boronic acid pinacol ester
C14H20BNO4 (277.14853100000005)
2-AMINO-4-(4-METHOXY-PHENYL)-5-METHYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
2-AMINO-2-(3,4,5-TRIMETHOXYPHENYL)ACETIC ACID HYDROCHLORIDE
Spiro[2H-1-benzopyran-2,2-[2H]indole],1,3-dihydro-1,3,3-trimethyl-
5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
5-Fluoro-4-[2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-y l]-2-pyrimidinamine
2-AMINO-4-(5-METHYLFURAN-2-YL)-5H-INDENO[1,2-D]PYRIMIDIN-5-ONE
Methyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate
C14H20BNO4 (277.14853100000005)
Ethylmethylthiambutene
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
6-METHYL-N-(4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL)BENZENE-1,3-DIAMINE
N-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)HYDRAZINECARBOTHIOAMIDE
C12H15N5OS (277.09972600000003)
Ganciclovir sodium
C9H12N5NaO4 (277.07869519999997)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
ETHYL 3-(2-CARBOXY-VINYL)-5-FLUORO-1H-INDOLE-2-CARBOXYLATE
DL-3-(4-BIPHENYL)ALANINE HYDROCHLORIDE
C15H16ClNO2 (277.08695059999997)
2-(p-tolylaminomethylene)malonic acid diethyl ester
2,4,5-TRIFLUORO-N-(1-HYDROXY-2-METHYL PROPAN-2-YL)-3-METHOXYBENZAMIDE
4-benzyl-2-methyl-5-oxomorpholine-3-carboxylic acid ethyl ester
(2S,3R)-2-Methyl-5-oxo-4-(phenylmethyl)-3-Morpholinecarboxylic acid ethyl ester
(2R,3S)-2-Methyl-5-oxo-4-(phenylmethyl)-3-Morpholinecarboxylic acid ethyl ester
Methyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
C14H20BNO4 (277.14853100000005)
2-Amino-9-[(1S,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one
3-(3-hydroxypropyl)-7,8-dimethoxy-1,3-dihydro-2H-benzo[d]azepin-2-one
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one
2-(tert-butoxycarbonylamino)-2,3-dihydro-1H-indene-2-carboxylic acid
4-HYDRAZINOCARBONYL-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
(3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid
ethyl 5-amino-4-(2-nitrophenyl)-1,2-oxazole-3-carboxylate
(1S,2S)-4-benzyl-2-(ethoxycarbonyl)cyclopentane-1-carboxylic aci
ethyl 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxylate
C15H16ClNO2 (277.08695059999997)
4-ALLYL-5-[(4-METHOXYPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL
3-hydroxy-N-(4-methylphenyl)naphthalene-2-carboxamide
(3-((3,4-Difluorophenyl)carbamoyl)phenyl)boronic acid
7-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
4-(4-ACETYL-1-PIPERAZINYL)-3-AMINO-BENZOIC ACID METHYL ESTER
1,2,3,4-TETRAHYDRO-6-METHYL-4-(4-NITROPHENYL)-2-OXO-5-PYRIMIDINECARBOXYLIC ACID
2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid
4-Amino-3-methoxycarbonylphenylboronic acid pinacol ester
C14H20BNO4 (277.14853100000005)
3-(2-methylphenoxy)-3-phenylpropan-1-amine,hydrochloride
N-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
C14H20BNO4 (277.14853100000005)
(4-(1-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPROPYL)PHENYL)BORONIC ACID
C14H20BNO4 (277.14853100000005)
1-(2-Methyl-3-nitrophenyl)-4-oxocyclohexanecarboxylic acid
1-CYCLOPROPYL-7-FLUORO-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
(1S,2R)-1-(TERT-BUTOXYCARBONYLAMINO)-2-PHENYLCYCLOPROPANECARBOXYLIC ACID
1-(Benzyloxycarbonyl)-6-Methylpiperidine-3-Carboxylic Acid
4-[3-(3-Nitrophenyl)-1,2,4-oxadiazol-5-YL]butanoic acid
4,6-Diamidino-2-phenylindole
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors
Elliptinium
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents
2-chloro-N-(1-phenyl-3-propyl-1H-pyrazol-5-yl)acetamide
C14H16ClN3O (277.09818359999997)
5-Piperidinopyrazolo[1,5-a]quinazoline-3-carbonitrile
2-amino-N-(4-ethylphenyl)-4-oxo-5,6-dihydro-4H-1,3-thiazine-6-carboxamide
3-(3,5-dimethoxyphenyl)-4-prop-2-enyl-1H-1,2,4-triazole-5-thione
ethyl 2-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]acetate
2-[3-(4-Methylphenyl)acryloyl]-1,2,3,4-tetrahydroisoquinoline
Triphenylmethylphosphonium
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents
trans-Dimethyl 1-benzylpyrrolidine-3,4-dicarboxylate
(2E)-4-((1-(2,6-Dimethylphenoxy)-2-propanyl)amino)-4-oxo-2-butenoic acid
2-(5-Hydroxy-naphthalen-1-YL)-1,3-benzooxazol-6-OL
C17H11NO3 (277.07388960000003)
3-(6-Hydroxy-naphthalen-2-YL)-benzo[D]isooxazol-6-OL
C17H11NO3 (277.07388960000003)
(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one
N-(1-Benzyl-3,3,3-trifluoro-2,2-dihydroxy-propyl)-acetamide
(Z)-2-[2-(4-Methylpiperazin-1-Yl)benzyl]diazenecarbothioamide
2-(2,6-Diaminohexanoylamino)-4-methylsulfanylbutanoic acid
2-Amino-5-[[[(1S,4S,5R)-4,5-dihydroxy-2-cyclopenten-1-yl]amino]methyl]-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one Dihydrochloride
pentalenolactone F(1-)
A monocarboxylic acid anion that is the conjugate base of pentalenolactone F, obtained by deprotonation of the carboxy group; major species at pH 7.3.
S-(8-amino-8-oxo-1-sulfanyloctan-3-yl) 2-methylpropanethioate
(2R)-2-amino-3-(4-hydroxy-1-oxononan-3-yl)sulfanylpropanoic acid
2-Amino-5-((((1S,4S,5R)-4,5-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-1,7-dihydro-4H-pyrrolo(2,3-D)pyrimidin-4-one
4-Amino-5-(2,4-diamino-4-oxobutanoyl)peroxy-5-oxopentanoic acid
(2R,3S,5R)-5-(4,5-Dihydroimidazo[2,1-f]purin-3-yl)-2-(hydroxymethyl)oxolan-3-ol
Thr-Ala-Ser
A tripeptide composed of L-threonine, L-alanine, and L-serine joined by peptide linkages.
N-(5-cyclohexyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide
N-[4-cyano-2-(1-naphthalenyl)-5-oxazolyl]acetamide
3-[(6-Methoxy-4-methyl-2-quinolinyl)thio]propanoic acid
2-(4-Oxo-6,8-dioxabicyclo[3.2.1]octan-2-yl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione
1-Isobutylsulfanylmethyl-2,8,9-trioxa-5-aza-1-sila-bicyclo[3.3.3]undecane
methyl 1-[(3S)-3,4-dihydroxy-2-methylbutan-2-yl]indole-3-carboxylate
5-[(3-Methoxyphenyl)iminomethyl]-2,2-dimethyl-1,3-dioxane-4,6-dione
(3R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyhexanoate
(3R,5R)-5-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyhexanoate
5-{[(2-Amino-6-isopropylpyrimidin-4-YL)amino]methyl}-1,2,4-oxadiazole-3-carboxamide
6-Amino-1-benzyl-3-methyl-5-(oxidoamino)-2-sulfanylidenepyrimidin-4-one
[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl] 4-hydroxy-3-methoxybenzoate
gamma-Glu-Met(1-)
A peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of gamma-Glu-Met. Major species at pH 7.3.
carboxy-ptio
A mmeber of the class of imidazolines and organic radical that is 4,4,5,5-tetramethyl-3-oxo-4,5-dihydro-1H-3lambda(5)-imidazol-1-yl]oxidanyl substituted at position 2 by a 4-carboxyphenyl group.
(2e)-2-methyl-5-[(1s,3r,6s,9r)-6-methyl-8-oxo-7-oxatricyclo[4.3.0.0³,⁹]nonan-9-yl]-4-oxopent-2-enimidic acid
3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,11,14,16,18-heptaen-13-one
C17H11NO3 (277.07388960000003)
3-hydroxy-6-(1h-indol-3-yloxy)-4-methylhexanoic acid
(5r,6r,10z)-6-hydroxy-2-methoxy-3-methylidene-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,4,7-trione
(2s)-2-(hydroxymethyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile
4-[(2s)-2,3-dihydroxy-3-methylbutoxy]-1-methylquinolin-2-one
16-hydroxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,9(17),11,13-heptaene-8,15-dione
C17H11NO3 (277.07388960000003)